Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 5/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | FNTA | P49354 | 1/20 | 0.43 |
| ▸ | FNTB | P49356 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | MIF | P14174 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30050175 | 0.99 | CXCR4 (0.53) | CXCR4HDAC1HDAC6CYP3A4TDP1 | |
| SCHEMBL3624643 | 0.99 | CXCR4 (0.53) | CXCR4HDAC1HDAC6CYP3A4TDP1 | |
| SCHEMBL31174256 | 0.99 | CXCR4 (0.53) | CXCR4HDAC1HDAC6CYP3A4TDP1 | |
| SCHEMBL31189926 | 0.99 | CXCR4 (0.53) | CXCR4HDAC1HDAC6CYP3A4TDP1 | |
| SCHEMBL2085172 | 0.98 | CXCR4 (0.52) | CXCR4HDAC1HDAC6CYP3A4TDP1 | |
| SCHEMBL4760091 | 0.85 | CXCR4 (0.47) | CXCR4HDAC1HDAC6CYP3A4FNTA | |
| SCHEMBL2083452 | 0.84 | CXCR4 (0.49) | CXCR4HDAC1HDAC6CYP3A4CYP2D6 | |
| SCHEMBL14275072 | 0.84 | CXCR4 (0.49) | CXCR4HDAC1HDAC6CYP3A4CYP2D6 | |
| SCHEMBL5061643 | 0.84 | CXCR4 (0.47) | CXCR4HDAC1HDAC6CYP3A4FNTA | |
| SCHEMBL4713902 | 0.83 | CXCR4 (0.46) | CXCR4HDAC1HDAC6TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080171740-A1 | Chemical Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2008-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171740-A1 | Chemical Compounds | CXCR4, CCR5, CXCR3 | CXCR4 1/4885HDAC1 1044/4885HDAC6 705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.